Use of Telehealth for Opioid Use Disorder Treatment in Safety Net Primary Care Settings: A Mixed-Methods Study

References

• Alexander, K., Pogorzelska-Maziarz, M., Gerolamo, A., Hassen, N., Kelly, E. L., & Rising, K. L. (2021). The impact of COVID-19 on healthcare delivery for people who use opioids: A scoping review. Substance Abuse Treatment, Prevention, and Policy, 16(1), 60. https://doi.org/10.1186/s13011-021-00395-6
   PubMed Web of Science ®Google Scholar
• Angier, H., Fleishman, J., Gordon, L., Cohen, D. J., Cantone, R. E., & Bailey, S. R. (2021). Tier-based treatment for opioid use disorder in the primary care setting. Families, Systems & Health : The Journal of Collaborative Family Healthcare, 39(2), 345–350. https://doi.org/10.1037/fsh0000619
   PubMed Web of Science ®Google Scholar
• Aronowitz, S. V., Engel-Rebitzer, E., Dolan, A., Oyekanmi, K., Mandell, D., Meisel, Z., South, E., & Lowenstein, M. (2021). Telehealth for opioid use disorder treatment in low-barrier clinic settings: An exploration of clinician and staff perspectives. Harm Reduction Journal, 18(1), 119–119. https://doi.org/10.1186/s12954-021-00572-7
   PubMed Web of Science ®Google Scholar
• Barsky, B. A., Busch, A. B., Patel, S. Y., Mehrotra, A., & Huskamp, H. A. (2022). Use of telemedicine for buprenorphine inductions in patients with commercial insurance or Medicare advantage. JAMA Network Open, 5(1), e2142531-e2142531. https://doi.org/10.1001/jamanetworkopen.2021.42531
   Web of Science ®Google Scholar
• Burns, M., Tang, L., Chang, C.-C H., Kim, J. Y., Ahrens, K., Allen, L., Cunningham, P., Gordon, A. J., Jarlenski, M. P., Lanier, P., Mauk, R., McDuffie, M. J., Mohamoud, S., Talbert, J., Zivin, K., & Donohue, J. (2022). Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: A retrospective cohort study. Addiction (Abingdon, England), 117(12), 3079–3088. https://doi.org/10.1111/add.15959
   PubMed Web of Science ®Google Scholar
• Butzner, M., & Cuffee, Y. (2021). Telehealth interventions and outcomes across rural communities in the United States: Narrative review. Journal of Medical Internet Research, 23(8), e29575. https://doi.org/10.2196/29575
   PubMed Web of Science ®Google Scholar
• Cance, J. D., & Doyle, E. (2020). Changes in outpatient buprenorphine dispensing during the COVID-19 pandemic. JAMA, 324(23), 2442–2444. https://doi.org/10.1001/jama.2020.22154
   PubMed Web of Science ®Google Scholar
• Chang, J. E., Lindenfeld, Z., Albert, S. L., Massar, R., Shelley, D., Kwok, L., Fennelly, K., & Berry, C. A. (2021). Telephone vs. video visits during COVID-19: Safety-net provider perspectives. Journal of the American Board of Family Medicine : JABFM, 34(6), 1103–1114. https://doi.org/10.3122/jabfm.2021.06.210186
   PubMed Web of Science ®Google Scholar
• Chu, R. P., De Lew, N., & Sommers, B. D. (2021, July). State medicaid telehealth policies before and during the COVID-19 public health emergency. Department of Health & Human Services, Assistant Secretary for Planning and Evaluation, Office of Health Policy.
   Google Scholar
• Connolly, S. L., Miller, C. J., Gifford, A. L., & Charness, M. E. (2022). Perceptions and use of telehealth among mental health, primary, and specialty care clinicians during the COVID-19 pandemic. JAMA Network Open, 5(6), e2216401. https://doi.org/10.1001/jamanetworkopen.2022.16401
   PubMed Web of Science ®Google Scholar
• Der-Martirosian, C., Chu, K., Steers, W. N., Wyte-Lake, T., Balut, M. D., Dobalian, A., Heyworth, L., Paige, N. M., & Leung, L. (2022). Examining telehealth use among primary care patients, providers, and clinics during the COVID-19 pandemic. BMC Primary Care, 23(1), 155. https://doi.org/10.1186/s12875-022-01738-3
   PubMedGoogle Scholar
• Frost, M. C., Zhang, L., Kim, H. M., & Lin, L. (2022). Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. JAMA Network Open, 5(10), e2236298. https://doi.org/10.1001/jamanetworkopen.2022.36298
   PubMed Web of Science ®Google Scholar
• Gibbons, J. B., McCullough, J. S., Zivin, K., Brown, Z. Y., & Norton, E. C. (2022). Association between buprenorphine treatment gaps, opioid overdose, and health care spending in US Medicare beneficiaries with opioid use disorder. JAMA Psychiatry, 79(12), 1173–1179. https://doi.org/10.1001/jamapsychiatry.2022.3118
   PubMed Web of Science ®Google Scholar
• Hailu, R., Mehrotra, A., Huskamp, H. A., Busch, A. B., & Barnett, M. L. (2023). Telemedicine use and quality of opioid use disorder treatment in the US during the COVID-19 pandemic. JAMA Network Open, 6(1), e2252381. https://doi.org/10.1001/jamanetworkopen.2022.52381
   PubMedGoogle Scholar
• Hartung, D. M., Markwardt, S., Johnston, K., Geddes, J., Baker, R., Leichtling, G., Hildebran, C., Chan, B., Cook, R. R., McCarty, D., Ghitza, U., & Korthuis, P. T. (2022). Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: A retrospective cohort study. Addiction Science & Clinical Practice, 17(1), 45. https://doi.org/10.1186/s13722-022-00318-1
   PubMed Web of Science ®Google Scholar
• Hilty, D. M., Ferrer, D. C., Parish, M. B., Johnston, B., Callahan, E. J., & Yellowlees, P. M. (2013). The effectiveness of telemental health: A 2013 review. Telemedicine Journal and e-Health : The Official Journal of the American Telemedicine Association, 19(6), 444–454. https://doi.org/10.1089/tmj.2013.0075
   PubMed Web of Science ®Google Scholar
• Hilty, D., Yellowlees, P. M., Parrish, M. B., & Chan, S. (2015). Telepsychiatry: Effective, evidence-based, and at a tipping point in health care delivery? The Psychiatric Clinics of North America, 38(3), 559–592. https://doi.org/10.1016/j.psc.2015.05.006
   PubMed Web of Science ®Google Scholar
• Hughes, P. M., Verrastro, G., Fusco, C. W., Wilson, C. G., & Ostrach, B. (2021). An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic. The Journal of Rural Health : official Journal of the American Rural Health Association and the National Rural Health Care Association, 37(3), 467–472. https://doi.org/10.1111/jrh.12570
   PubMed Web of Science ®Google Scholar
• Jones, C. M., Shoff, C., Hodges, K., Blanco, C., Losby, J. L., Ling, S. M., & Compton, W. M. (2022). Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among medicare beneficiaries before and during the COVID-19 pandemic. JAMA Psychiatry, 79(10), 981. https://doi.org/10.1001/jamapsychiatry.2022.2284
   PubMed Web of Science ®Google Scholar
• LaBelle, C. T., Han, S. C., Bergeron, A., & Samet, J. H. (2016). Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of the Massachusetts collaborative care model in community health centers. Journal of Substance Abuse Treatment, 60, 6–13. https://doi.org/10.1016/j.jsat.2015.06.010
   PubMed Web of Science ®Google Scholar
• Langarizadeh, M., Tabatabaei, M. S., Tavakol, K., Naghipour, M., Rostami, A., & Moghbeli, F. (2017). Telemental health care, an effective alternative to conventional mental care: A systematic review. Acta Informatica Medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za Medicinsku Informatiku BiH, 25(4), 240–246. https://doi.org/10.5455/aim.2017.25.240-246
   PubMedGoogle Scholar
• Lin, L. A., Zhang, L., Kim, H. M., & Frost, M. C. (2022). Impact of COVID-19 telehealth policy changes on buprenorphine treatment for opioid use disorder. American Journal of Psychiatry, 179(10), 740–747. https://doi.org/10.1176/appi.ajp.21111141
   PubMed Web of Science ®Google Scholar
• Mahmoud, H., Naal, H., Whaibeh, E., & Smith, A. (2022). Telehealth-based delivery of medication-assisted treatment for opioid use disorder: A critical review of recent developments. Current Psychiatry Reports, 24(9), 375–386. https://doi.org/10.1007/s11920-022-01346-z
   PubMed Web of Science ®Google Scholar
• Mattocks, K. M., Moore, D. T., Wischik, D. L., Lazar, C. M., & Rosen, M. I. (2022). Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 139, 108777. https://doi.org/10.1016/j.jsat.2022.108777
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences Engineering and Medicine. (2019). Medications for opioid use disorder save lives. https://www.nap.edu/catalog/25310/medications-for-opioid-use-disorder-save-lives
   Google Scholar
• Patel, S. Y., Ortiz, E. G., Barsky, B. A., Huskamp, H. A., Busch, A. B., & Mehrotra, A. (2022). Patient and clinician characteristics associated with use of telemedicine for buprenorphine induction among Medicare beneficiaries. Journal of General Internal Medicine, 37(14), 3758–3761. https://doi.org/10.1007/s11606-022-07633-y
   PubMed Web of Science ®Google Scholar
• Riedel, L., Uscher-Pines, L., Mehrotra, A., Busch, A. B., Barnett, M. L., Raja, P., & Huskamp, H. A. (2021). Use of telemedicine for opioid use disorder treatment – Perceptions and experiences of opioid use disorder clinicians. Drug and Alcohol Dependence, 228, 108999. https://doi.org/10.1016/j.drugalcdep.2021.108999
   PubMed Web of Science ®Google Scholar
• Rural Health Information Hub. (2021). Rural Health Clinics (RHCs). https://www.ruralhealthinfo.org/topics/rural-health-clinics
   Google Scholar
• The American Society of Addiction Medicine. (2020). COVID-19-ensuring access to care in opioid treatment programs. https://www.asam.org/quality-care/clinical-recommendations/covid/access-to-care-in-opioid-treatment-program
   Google Scholar
• Thomas, D. R. (2006). A General Inductive Approach for Analyzing Qualitative Evaluation Data. American Journal of Evaluation, 27(2), 237–246. https://doi.org/10.1177/1098214005283748
   Web of Science ®Google Scholar
• Thornton, J. D., Varisco, T. J., Bapat, S. S., Downs, C. G., & Shen, C. (2020). Impact of COVID-19 related policy changes on buprenorphine dispensing in Texas. Journal of Addiction Medicine, 14(6), e372–e374. https://doi.org/10.1097/ADM.0000000000000756
   PubMed Web of Science ®Google Scholar
• Tilhou, A. S., Dague, L., Saloner, B., Beemon, D., & Burns, M. (2022). Trends in engagement with opioid use disorder treatment among medicaid beneficiaries during the COVID-19 pandemic. JAMA Health Forum, 3(3), e220093-e220093. https://doi.org/10.1001/jamahealthforum.2022.0093
   Google Scholar
• Uscher-Pines, L., Sousa, J., Jones, M., Whaley, C., Perrone, C., McCullough, C., & Ober, A. J. (2021). Telehealth use among safety-net organizations in California during the COVID-19 pandemic. JAMA, 325(11), 1106–1107. https://doi.org/10.1001/jama.2021.0282
   PubMed Web of Science ®Google Scholar
• Uscher-Pines, L., Sousa, J., Raja, P., Mehrotra, A., Barnett, M., & Huskamp, H. A. (2020). Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine. Journal of Substance Abuse Treatment, 118, 108124. https://doi.org/10.1016/j.jsat.2020.108124
   PubMed Web of Science ®Google Scholar